Eur Rev Med Pharmacol Sci 2014; 18 (22): 3349-

Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson’s disease

W.H. Jost, M. Friede, J. Schnitker

Parkinson-Klinik Wolfach, University of Freiburg, Wolfach, Germany. w.jost@parkinson-klinik.de

To cite this article

W.H. Jost, M. Friede, J. Schnitker
Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson’s disease

Eur Rev Med Pharmacol Sci
Year: 2014
Vol. 18 - N. 22
Pages: 3349-

Publication History

Published online: 27 Nov 2014

Keywords Related articles:

  1. Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson’s disease
  2. Investigation of oral selegiline and rasagiline administration on QT interval in conscious rabbits
  3. Early postoperative hemodynamic performances of stented versus stentless aortic xenografts in aortic valve replacement in elderly patients: a comparative study
  4. Nitric oxide and peroxynitrite serum levels in Parkinson’s disease: correlation of oxidative stress and the severity of the disease
  5. The association between lysosomal protein glucocerebrosidase and Parkinson’s disease